NCT05122897 Investigation of Biofilm Formation on Temporary push-on Rings of Implant Crowns
| NCT ID | NCT05122897 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Basel, Switzerland |
| Condition | Dental Plaque |
| Study Type | INTERVENTIONAL |
| Enrollment | 33 participants |
| Start Date | 2022-01-11 |
| Primary Completion | 2026-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 33 participants in total. It began in 2022-01-11 with a primary completion date of 2026-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This in-vivo study investigates early (48h), mature (2 weeks) and long-term (3 months) biofilm formation and composition on temporary push-on cones (exchangeable conical rings) made of noble-alloy-based materials (Pagalinor, PA) in comparison to Titanium-6Aluminum-7Niobium alloy (TAN) presently used in the transmucosal portion of dental implant abutments.
Eligibility Criteria
Inclusion Criteria: * Informed Consent signed by the subject * Presence of one or more bone level titanium implant prior to insertion of the final restoration * No systemic illness * No heavy smoking (smoking \<10 cigarettes/day) * No pregnancy * No active periodontitis (probing pocket depth ≤4 mm) * No pharmacological treatment or antibiotic therapy during or up to three months before the study Exclusion Criteria: * Systemic illness (e.g. Diabetes) * Heavy smoking (smoking \>10 cigarettes/day) * Known or suspected non-compliance, drug or alcohol abuse * Pregnancy * Active periodontitis (probing pocket depth \>4 mm) * Pharmacological treatment or antibiotic therapy during or up to three months before the study
Contact & Investigator
Nicola U. Zitzmann, Prof. Dr.
PRINCIPAL INVESTIGATOR
University Center for Dental Medicine Basel
Frequently Asked Questions
Who can join the NCT05122897 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Dental Plaque. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05122897 currently recruiting?
Yes, NCT05122897 is actively recruiting participants. Contact the research team at n.zitzmann@unibas.ch for enrollment information.
Where is the NCT05122897 trial being conducted?
This trial is being conducted at Basel, Switzerland.
Who is sponsoring the NCT05122897 clinical trial?
NCT05122897 is sponsored by University Hospital, Basel, Switzerland. The principal investigator is Nicola U. Zitzmann, Prof. Dr. at University Center for Dental Medicine Basel. The trial plans to enroll 33 participants.